Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium Carbonate in ALS
NCT00790582Phase 2Completed
- Sponsor
- Forbes Norris MDA/ALS Research Center
- Start
- May 2008
- Primary completion
- Mar 2010
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of lithium carbonate in amyotrophic lateral sclerosis (ALS), sponsored by Forbes Norris MDA/ALS Research Center. Started May 2008; status: completed.
02
Drugs
lithium carbonate
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT00790582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00790582.